[文献资料]参 考 文 献

Treatment with therapies matched to oncogenic drivers improves survival in patients with lung cancers：results from The Lung Cancer Mutation Consortium（LCMC）. Paper presented at：IASLC 15th World Conference on Lung Cancer。Randomized phase II trial of erloti ......